Company
VoxCell Bioinnovation
Human-centric preclinical models
Also known as VoxCell, VoxCell BioInnovation Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- VoxCell BioInnovation Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
Perfusable, vascularized human tissue models reveal drug distribution, target engagement, and potential liabilities, without relying on animal models.
Funding snapshot
- Total raised
- $3.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $2.2M2026-08-19
Funding rounds
- Round, 2026
- $2.2M2026-08-19, SEC form D sold
- Round, 2025
- $1.7M2025-02-28, SEC form D sold, 10 investors
- Round, 2023
- $1.5M2023-12-20, SEC form D sold, 38 investors
Products
- Other
- Vascularized human tissue models
Loading relationship preview